Sorrento Therapeutics

Sorrento Therapeutics

Biotechnology, 4955 Directors Pl, San Diego, California, 92121, United States, 501-1000 Employees

sorrentotherapeutics.com

  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is SORRENTO THERAPEUTICS

Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical need...

Read More

map
  • 4955 Directors Pl, San Diego, California, 92121, United States Headquarters: 4955 Directors Pl, San Diego, California, 92121, United States
  • 2009 Date Founded: 2009
  • 501-1000 Employees: 501-1000
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 999990 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SORRENTO THERAPEUTICS

Sorrento Therapeutics Org Chart and Mapping

Employees

Alisa Jean

Facilities Coordinator

Megan Truong

Quality Assurance Associate II

Wagoner Loveless

Product Development and Manufacturing

Robin Muckerman

Process Development Associate

Samantha Arizmendez

Document Control Specialist

Similar Companies to Sorrento Therapeutics

Allogene Therapeutics

  • 201-500 201-500
  • 1 Million to 5 Million $ 1 Million to 5 Million

Artiva Biotherapeutics

  • 51-200 51-200
  • 10 Million to 25 Million $ 10 Million to 25 Million

Mirati Therapeutics

  • 201-500 201-500
  • 50 Million to 100 Million $ 50 Million to 100 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Sorrento Therapeutics

Answer: Sorrento Therapeutics's headquarters are located at 4955 Directors Pl, San Diego, California, 92121, United States

Answer: Sorrento Therapeutics's phone number is 85********

Answer: Sorrento Therapeutics's official website is https://sorrentotherapeutics.com

Answer: Sorrento Therapeutics's revenue is $50 Million to $100 Million

Answer: Sorrento Therapeutics's SIC: 2836

Answer: Sorrento Therapeutics's NAICS: 999990

Answer: Sorrento Therapeutics has 501-1000 employees

Answer: Sorrento Therapeutics is in Biotechnology

Answer: Sorrento Therapeutics top competitors include: Allogene Therapeutics , Artiva Biotherapeutics , Mirati Therapeutics

Answer: Sorrento Therapeutics contact info: Phone number: 85******** Website: https://sorrentotherapeutics.com

Answer: Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical needs. Our vision is to leverage our proprietary G-MABTM library in conjunction with a proprietary targeted delivery modalities to generate the next generation of therapeutics for treating cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. These modalities include proprietary chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-TTM), antibody-drug conjugates (ADCs), oncolytic virus (SeprehvecTM), lymphatic drug targeting (SOFUSA), as well as bispecific antibody approaches. We are additionally developing pain management solutions, including our clinical candidates resiniferatoxin (RTX) and SEMDEXATM. In response to the global SARS-CoV-2 (COVID-19) pandemic, we are also developing and conducting clinical studies for potential coronavirus antiviral therapies and vaccines, including Abivertinib, COVI-MSCTM, COVI-AMGTM, COVIDROPSTM, and COVI SHIELDTM, and diagnostic test solutions, such as COVISTIXTM and COVITRACKTM.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access